Xconomy
OCTOBER 7, 2016
. —Alnylam Pharmaceuticals (NASDAQ: ALNY ) of Cambridge, MA, said that it would shelve its drug revusiran after 18 patients died in a Phase 3 study to treat the rare disease transthyretin amyloidosis. —The 2016 Nobel Prize for Physiology or Medicine went to Yoshinori Ohsumi of the Tokyo Institute of Technology.
Xconomy
JULY 15, 2016
After last week’s revelation of three patient deaths in its leading cancer immunotherapy trial, the FDA suspended the study. All eyes are on Holmes, who is scheduled to present data from the company’s technology at a medical conference on August 1. Sarepta’s drug is currently under an FDA review.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Xconomy
JUNE 17, 2016
Despite technical differences and the early nature of the data that made comparison difficult, Wall Street declared Spark this week’s winner. . —More updates from the hematology meeting: Philadelphia-based Spark Therapeutics (NASDAQ: ONCE ) and Dutch firm UniQure (NASDAQ: QURE ) both updated their hemophilia B gene therapy programs.
Both Sides of the Table
APRIL 6, 2020
You need to: study the rules, make sure that you don’t violate the “affiliate rule” (more later), consult with your Company Counsel, consult with your board and investors and then make your own determination. If you do massive layoffs (RIFs) you can assume that you will need to repay your loan since the intent of the loan is to protect jobs.
Expert insights. Personalized for you.
77 
Let's personalize your content